APA (7th ed.) Citation

AV, M., HT, V., AB, L., & V, N. (2020). US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development. Clinical and translational science, 13(4), 652. https://doi.org/10.1111/cts.12755

Chicago Style (17th ed.) Citation

AV, Morant, Vestergaard HT, Lassen AB, and Navikas V. "US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development." Clinical and Translational Science 13, no. 4 (2020): 652. https://doi.org/10.1111/cts.12755.

MLA (9th ed.) Citation

AV, Morant, et al. "US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development." Clinical and Translational Science, vol. 13, no. 4, 2020, p. 652, https://doi.org/10.1111/cts.12755.